BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 26571100)

  • 1. Safeguarding CRISPR-Cas9 gene drives in yeast.
    DiCarlo JE; Chavez A; Dietz SL; Esvelt KM; Church GM
    Nat Biotechnol; 2015 Dec; 33(12):1250-1255. PubMed ID: 26571100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuning CRISPR-Cas9 Gene Drives in
    Roggenkamp E; Giersch RM; Schrock MN; Turnquist E; Halloran M; Finnigan GC
    G3 (Bethesda); 2018 Mar; 8(3):999-1018. PubMed ID: 29348295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAR1 deletion by CRISPR/Cas9 reduces formation of ethyl carbamate from ethanol fermentation by Saccharomyces cerevisiae.
    Chin YW; Kang WK; Jang HW; Turner TL; Kim HJ
    J Ind Microbiol Biotechnol; 2016 Nov; 43(11):1517-1525. PubMed ID: 27573438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating CRISPR gene drive activity through nucleocytoplasmic localization of Cas9 in
    Goeckel ME; Basgall EM; Lewis IC; Goetting SC; Yan Y; Halloran M; Finnigan GC
    Fungal Biol Biotechnol; 2019; 6():2. PubMed ID: 30766726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene drives in our future: challenges of and opportunities for using a self-sustaining technology in pest and vector management.
    Collins JP
    BMC Proc; 2018; 12(Suppl 8):9. PubMed ID: 30079101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
    Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large fragment deletion using a CRISPR/Cas9 system in Saccharomyces cerevisiae.
    Hao H; Wang X; Jia H; Yu M; Zhang X; Tang H; Zhang L
    Anal Biochem; 2016 Sep; 509():118-123. PubMed ID: 27402178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient genome editing by CRISPR/Cas9 with a tRNA-sgRNA fusion in the methylotrophic yeast Ogataea polymorpha.
    Numamoto M; Maekawa H; Kaneko Y
    J Biosci Bioeng; 2017 Nov; 124(5):487-492. PubMed ID: 28666889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of genome engineering using the CRISPR-Cas9 system in C. glabrata wild-type and lig4 strains.
    Cen Y; Timmermans B; Souffriau B; Thevelein JM; Van Dijck P
    Fungal Genet Biol; 2017 Oct; 107():44-50. PubMed ID: 28822858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
    Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
    Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
    Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
    Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of genomic sites for CRISPR/Cas9-based genome editing in the Vitis vinifera genome.
    Wang Y; Liu X; Ren C; Zhong GY; Yang L; Li S; Liang Z
    BMC Plant Biol; 2016 Apr; 16():96. PubMed ID: 27098585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of the CRISPR-Cas9 system in kidney research.
    Higashijima Y; Hirano S; Nangaku M; Nureki O
    Kidney Int; 2017 Aug; 92(2):324-335. PubMed ID: 28433382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 in insects: Applications, best practices and biosafety concerns.
    Taning CNT; Van Eynde B; Yu N; Ma S; Smagghe G
    J Insect Physiol; 2017 Apr; 98():245-257. PubMed ID: 28108316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma.
    Liu T; Shen JK; Li Z; Choy E; Hornicek FJ; Duan Z
    Cancer Lett; 2016 Apr; 373(1):109-118. PubMed ID: 26806808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System.
    Altenbuchner J
    Appl Environ Microbiol; 2016 Sep; 82(17):5421-7. PubMed ID: 27342565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas9: a new and promising player in gene therapy.
    Xiao-Jie L; Hui-Ying X; Zun-Ping K; Jin-Lian C; Li-Juan J
    J Med Genet; 2015 May; 52(5):289-96. PubMed ID: 25713109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas9 Genome Engineering in Saccharomyces cerevisiae Cells.
    Ryan OW; Poddar S; Cate JH
    Cold Spring Harb Protoc; 2016 Jun; 2016(6):. PubMed ID: 27250940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can CRISPR-Based Gene Drive Be Confined in the Wild? A Question for Molecular and Population Biology.
    Marshall JM; Akbari OS
    ACS Chem Biol; 2018 Feb; 13(2):424-430. PubMed ID: 29370514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.